HA
AMRI

Heartland Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

Heartland Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-240,243
Closed -$4.18M – 240
2015
Q3 		$4.18M Hold
240,243
– – 0.15% 152
2015
Q2 		$4.86M Buy
240,243
+79,872
+50% +$1.54M 0.14% 171
2015
Q1 		$2.82M Buy
+160,371
New +$2.73M 0.07% 198

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors's AMRI Position: Q4 2015 in Review

Heartland Advisors sold out of Albany Molecular Research Inc (AMRI) in Q4 2015, closing a stake of 240,243 shares — an estimated $4.18M sold.

Heartland Advisors first reported a position in AMRI in Q1 2015 and held it in 3 quarters. The position peaked at $4.86M in Q2 2015. 151 funds tracked by Wall St. Rank hold AMRI as of Q4 2015.

  • Heartland Advisors reported no remaining Albany Molecular Research Inc position as of Q4 2015 after selling out during the quarter.
  • Heartland Advisors sold 240,243 Albany Molecular Research Inc shares in Q4 2015, an estimated $4.18M.
  • Heartland Advisors first reported a position in Albany Molecular Research Inc in Q1 2015 and held it in 3 quarters.
  • Heartland Advisors's Albany Molecular Research Inc position peaked at $4.86M in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2015.

Based on Heartland Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.